-Onconova Therapeutics Announces Encouraging Clinical Data Supporting The Anti-Cancer Activity Of Rigosertib-Nivolumab Combination In Advanced KRAS+ Non-Small Cell Lung Cancer

Press/Media

Period23 Sep 2021

Media coverage

1

Media coverage

  • Title-Onconova Therapeutics Announces Encouraging Clinical Data Supporting The Anti-Cancer Activity Of Rigosertib-Nivolumab Combination In Advanced KRAS+ Non-Small Cell Lung Cancer
    Media name/outletENP Newswire
    Date23/09/21
    PersonsRajwanth Veluswamy
View all 1
View less